Package Leaflet: Information for the Patient
VenlafaxineRetard Normon 225 mg prolonged-release hard capsules EFG
Venlafaxine
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
Venlafaxine Retard Normon contains the active substance venlafaxine.
Venlafaxine Retard Normon is an antidepressant that belongs to a group of medications called serotonin and norepinephrine reuptake inhibitors (SNRIs). This group of medications is used to treat depression and other conditions such as anxiety disorders. It is believed that people who are depressed and/or anxious have lower levels of serotonin and norepinephrine in the brain. The exact way antidepressants work is not fully understood, but they may help increase the levels of serotonin and norepinephrine in the brain.
Venlafaxine Retard Normon is a treatment for adults with depression. It is also a treatment for adults with the following anxiety disorders: generalized anxiety disorder, social anxiety disorder (fear or avoidance of social situations), panic disorder (panic attacks). Properly treating depressive and anxiety disorders is important to help you feel better. If left untreated, your condition may not improve or may worsen and become more difficult to treat.
Do not take Venlafaxine Retard Normon
Warnings and precautions
Consult your doctor or pharmacist beforestarting to take this medication:
Venlafaxine may cause a feeling of restlessness or difficulty sitting or standing still during the first few weeks of treatment. You should consult your doctor if this happens to you.
Some medications in the same group as Venlafaxine Retard Normon (called SSRIs/SNRIs) may cause symptoms of sexual dysfunction (see section 4). In some cases, these symptoms persist after stopping treatment.
Do not drink alcohol during treatment with Venlafaxine Retard Normon, as it may cause extreme fatigue and unconsciousness. Taking it with certain medications and/or alcohol may worsen symptoms of depression and other conditions, such as anxiety disorders.
Thoughts of suicide and worsening of your depression or anxiety disorder
If you are depressed and/or have anxiety disorders, you may sometimes have thoughts of harming yourself or suicide. This may increase when starting to take antidepressants, due to the fact that these medications take time to work, usually about two weeks but sometimes longer.
This is more likely to happen:
If you have thoughts of self-harm or suicide at any time, contact your doctor or go to the hospital immediately.
You may find it helpful to tell a relative or close friend that you are depressed or have an anxiety disorder and ask them to read this package leaflet. You can also ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behavior.
Dry mouth
Dry mouth has been reported in 10% of patients treated with venlafaxine. This may increase the risk of tooth decay (caries). Therefore, you should be careful with your dental hygiene.
Diabetes
Your blood glucose levels may be altered by this medication. Therefore, the doses of your diabetes medications may need to be adjusted.
Children and adolescents
Venlafaxine should not normally be used in the treatment of children and adolescents under 18 years of age. Additionally, you should know that in patients under 18 years of age, there is a greater risk of side effects such as suicidal attempts, suicidal thoughts, and hostility (predominantly aggression, confrontational behavior, and irritability) when taking this class of medications. Despite this, your doctor may prescribe this medication to patients under 18 years of age when they decide it is most convenient for the patient. If your doctor has prescribed this medication to a patient under 18 years of age and you wish to discuss this decision, please return to your doctor. You must inform your doctor if any of the above symptoms develop or worsen when these patients under 18 years of age are taking venlafaxine.
Additionally, long-term safety in relation to growth, maturity, and cognitive and behavioral development has not been demonstrated.
Taking Venlafaxine Retard Normon with other medications
Tell your doctor or pharmacist if you are using or have recently used or may need to use any other medication.
Your doctor must decide if you can take venlafaxine with other medications.
Do not start or stop taking any medication, including those sold without a prescription, natural remedies, and herbal products, before checking with your doctor or pharmacist.
Examples of these medications include:
The signs and symptoms of serotonin syndrome may include a combination of the following:
restlessness, hallucinations, loss of coordination, rapid heartbeat, increased body temperature, rapid changes in blood pressure, hyperactive reflexes, diarrhea, coma, nausea, vomiting.
In its most severe form, serotonin syndrome can resemble Neuroleptic Malignant Syndrome (NMS). The signs and symptoms of NMS may include a combination of fever, rapid heartbeat, sweating, severe muscle stiffness, confusion, increased muscle enzymes (determined by a blood test).
Tell your doctor immediately or go to the emergency room of the nearest hospital if you think you are experiencing serotonin syndrome.
Tell your doctor if you are taking medications that may alter your heart rhythm.
Some examples of these medications include:
The following medications may also interact with venlafaxine and should be used with caution. It is especially important to mention to your doctor or pharmacist if you are taking medications containing:
Taking Venlafaxine Retard Normon with food, drinks, and alcohol
Venlafaxine should be taken with food (see section 3 "How to take Venlafaxine Retard Normon").
Do not drink alcohol during treatment with Venlafaxine Retard Normon. Taking it with alcohol may cause extreme fatigue and unconsciousness, and worsen symptoms of depression and other conditions, such as anxiety disorders.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication. You should only take venlafaxine after discussing the possible benefits and risks to the unborn child with your doctor.
Make sure your midwife and/or doctor knows you are taking venlafaxine. When taken during pregnancy, similar medications (SSRIs) may increase the risk of a serious condition in newborns called persistent pulmonary hypertension of the newborn (PPHN), causing the baby to breathe faster and turn blue. These symptoms usually start within the first 24 hours after the baby's birth. If this happens to your baby, you must contact your midwife and/or doctor immediately.
If you are taking this medication during pregnancy, in addition to breathing problems, another symptom your baby may have at birth is feeding problems. If your baby has these symptoms at birth and you are concerned, contact your doctor and/or midwife, who can advise you.
If you take Venlafaxine Retard Normon in the final stage of pregnancy, there may be an increased risk of heavy vaginal bleeding shortly after delivery, especially if you have a history of bleeding disorders. Your doctor or midwife should know that you are taking Venlafaxine Retard Normon so they can advise you.
Venlafaxine passes into breast milk. There is a risk of an effect on the baby. Therefore, you should discuss this with your doctor, and they will decide whether you should stop breastfeeding or stop taking this medication.
Driving and using machines
Do not drive or operate tools or machines until you know how this medication affects you.
This medication can cause allergic reactions because it contains carmoisine. It may cause asthma, especially in patients allergic to acetylsalicylic acid.
Follow the instructions for administration of this medication indicated by your doctor exactly. In case of doubt, consult your doctor or pharmacist again.
The recommended initial dose for the treatment of depression, generalized anxiety disorder, and social anxiety disorder is 75 mg per day. Your doctor may gradually increase the dose and, if necessary, up to a maximum of 375 mg per day for depression. If you are being treated for panic disorder, your doctor will start with a lower dose (37.5 mg) and then gradually increase the dose. The maximum dose for generalized anxiety disorder, social anxiety disorder, and panic disorder is 225 mg/day.
Take this medication approximately at the same time each day, either in the morning or evening. The capsules should be swallowed whole with liquid and should not be opened, crushed, chewed, or dissolved.
Venlafaxine should be taken with food.
If you have liver or kidney problems, talk to your doctor, as you may need a different dose of this medication.
Do not stop taking this medication without consulting your doctor (see section "If you stop taking Venlafaxine Retard Normon").
If you take more Venlafaxine Retard Normon than you should
In case of overdose or accidental ingestion, contact your doctor, pharmacist, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount taken.
Overdose can put your life in danger, especially when taken simultaneously with certain medications and/or alcohol (see "Taking Venlafaxine Retard Normon with other medications").
The symptoms of a possible overdose may include palpitations, changes in the level of consciousness (ranging from drowsiness to coma), blurred vision, seizures or convulsions, and vomiting.
If you forget to take Venlafaxine Retard Normon
If you have not taken a dose, take it as soon as you remember. However, if it is already time for your next dose, skip the missed dose and take only a single dose as usual. Do not take a double dose to make up for missed doses. Do not take more than the daily dose of venlafaxine prescribed by your doctor in one day.
If you stop taking Venlafaxine Retard Normon
Do not stop taking your treatment or reduce the dose without your doctor's advice, even if you feel better. If your doctor believes you no longer need this medication, they may ask you to gradually reduce the dose before stopping treatment completely. It is known that side effects occur when people stop using this medication, especially when stopped suddenly or if the dose is reduced too quickly. Some patients may experience symptoms such as fatigue, dizziness, instability, headache, insomnia, nightmares, dry mouth, loss of appetite, nausea, diarrhea, nervousness, agitation, confusion, ringing in the ears, tingling, or, in rare cases, sensations of electric shock, weakness, sweating, seizures, or flu-like symptoms.
Your doctor will advise you on how to gradually stop taking this medication. If you experience any of these or other symptoms that bother you, consult your doctor for advice.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
If any of the following effects occur, do not take this medicine anymore. Tell your doctor immediately, or go to the emergency department of the nearest hospital:
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
In its most severe form, serotonin syndrome can resemble neuroleptic malignant syndrome (NMS). The signs and symptoms of NMS may include a combination of fever, rapid heartbeat, sweating, severe muscle stiffness, confusion, increased muscle enzymes (determined by a blood test).
Other adverse effects that you should inform your doctor aboutare (the frequency of these adverse effects is included in the list below “other adverse effects that may occur”):
Do not worry if you notice white balls or small granules in your stools after taking this medicine. Inside the capsules of this medicine, there are spheroids (small white balls) that contain the active ingredient (venlafaxine). These spheroids are released from the capsule in the stomach. As they circulate through the stomach and intestines, venlafaxine is slowly released. The “shell” of the spheroid does not dissolve and is eliminated in the stools. Therefore, even if you see spheroids in the stools, the dose of the medicine has been absorbed.
Other adverse effects that may occur
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
Very rare (may affect up to 1 in 10,000 people)
Frequency not known (cannot be estimated from the available data)
Venlafaxine sometimes produces unwanted effects that you may not be aware of, such as increased blood pressure or an abnormal heartbeat; slight changes in blood levels of liver enzymes, sodium or cholesterol. Less frequently, venlafaxine may reduce the function of blood platelets, leading to an increased risk of bruising or bleeding. Therefore, your doctor may want to perform occasional blood tests, especially if you have been taking venlafaxine for a long time.
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor, pharmacist or nurse, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: http://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging and the blister pack after “CAD”. The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines that you no longer need at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines that you no longer need. This way, you will help protect the environment.
Composition of Venlafaxine Retard Normon
The active ingredient is venlafaxine.
Venlafaxine Retard Normon 225 mg:
Each prolonged-release capsule contains 254.52 mg of venlafaxine hydrochloride, equivalent to 225 mg of venlafaxine base.
The other components are:
Capsule content:
Core:Microcrystalline cellulose, povidone, talc, anhydrous colloidal silica, magnesium stearate.
Coating:Ethyl cellulose, copovidone.
Capsule shell:
Gelatin, titanium dioxide (E171), carmoisine (E122).
Capsule printing ink:
Shellac (E904), propylene glycol (E1520), ammonium hydroxide (E527), carmine indigo (E132).
Appearance of the product and package contents
Venlafaxine Retard Normon 225 mg is a hard gelatin capsule, opaque pink, size “00”, with a wide and narrow circular band printed in blue ink, both on the body and on the cap of the capsule, and inside which are the mini-tablets.
Venlafaxine Retard Normon 225 mg is available in packs with aluminum-CFB, aluminum-PVC/Aclar white opaque or aluminum-PVC/PVdC white opaque blisters of 30 prolonged-release hard capsules.
Marketing authorization holder and manufacturer:
LABORATORIOS NORMON, S.A.
Ronda de Valdecarrizo, 6
28760 Tres Cantos, Madrid
Spain
Date of the last revision of this prospectus: May 2023
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es
The average price of VENLAFAXINE RETARD NORMON 225 mg PROLONGED-RELEASE HARD CAPSULES in October, 2025 is around 28.74 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.